Treatment of breast cancer in young women

Kathryn J Ruddy, Ann H. Partridge

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Caring for young women with breast cancer poses unique challenges to clinicians. Early-stage cancers are more likely to be more aggressive and recur in younger women, so aggressive treatment is often indicated. However, the disease and treatments a woman receives have the potential to be highly disruptive to functioning in many realms (e.g., home, work and school). Consideration of the unique issues facing young women early in the course of their care, including not only reducing risk of cancer recurrence and death, but also fertility, genetic and psychosocial concerns, is warranted for optimal care of young women with breast cancer.

Original languageEnglish (US)
Pages (from-to)171-180
Number of pages10
JournalClinical Practice
Volume9
Issue number2
DOIs
StatePublished - Mar 2012
Externally publishedYes

Fingerprint

Breast Neoplasms
Therapeutics
Fertility
Neoplasms
Recurrence

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

Treatment of breast cancer in young women. / Ruddy, Kathryn J; Partridge, Ann H.

In: Clinical Practice, Vol. 9, No. 2, 03.2012, p. 171-180.

Research output: Contribution to journalArticle

Ruddy, Kathryn J ; Partridge, Ann H. / Treatment of breast cancer in young women. In: Clinical Practice. 2012 ; Vol. 9, No. 2. pp. 171-180.
@article{24bb4c4669de41d8adf4b78c790e9326,
title = "Treatment of breast cancer in young women",
abstract = "Caring for young women with breast cancer poses unique challenges to clinicians. Early-stage cancers are more likely to be more aggressive and recur in younger women, so aggressive treatment is often indicated. However, the disease and treatments a woman receives have the potential to be highly disruptive to functioning in many realms (e.g., home, work and school). Consideration of the unique issues facing young women early in the course of their care, including not only reducing risk of cancer recurrence and death, but also fertility, genetic and psychosocial concerns, is warranted for optimal care of young women with breast cancer.",
author = "Ruddy, {Kathryn J} and Partridge, {Ann H.}",
year = "2012",
month = "3",
doi = "10.2217/cpr.11.137",
language = "English (US)",
volume = "9",
pages = "171--180",
journal = "Therapy",
issn = "2044-9038",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Treatment of breast cancer in young women

AU - Ruddy, Kathryn J

AU - Partridge, Ann H.

PY - 2012/3

Y1 - 2012/3

N2 - Caring for young women with breast cancer poses unique challenges to clinicians. Early-stage cancers are more likely to be more aggressive and recur in younger women, so aggressive treatment is often indicated. However, the disease and treatments a woman receives have the potential to be highly disruptive to functioning in many realms (e.g., home, work and school). Consideration of the unique issues facing young women early in the course of their care, including not only reducing risk of cancer recurrence and death, but also fertility, genetic and psychosocial concerns, is warranted for optimal care of young women with breast cancer.

AB - Caring for young women with breast cancer poses unique challenges to clinicians. Early-stage cancers are more likely to be more aggressive and recur in younger women, so aggressive treatment is often indicated. However, the disease and treatments a woman receives have the potential to be highly disruptive to functioning in many realms (e.g., home, work and school). Consideration of the unique issues facing young women early in the course of their care, including not only reducing risk of cancer recurrence and death, but also fertility, genetic and psychosocial concerns, is warranted for optimal care of young women with breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84858058286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858058286&partnerID=8YFLogxK

U2 - 10.2217/cpr.11.137

DO - 10.2217/cpr.11.137

M3 - Article

VL - 9

SP - 171

EP - 180

JO - Therapy

JF - Therapy

SN - 2044-9038

IS - 2

ER -